Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $18.37, but opened at $19.96. Ascentage Pharma Group International shares last traded at $20.05, with a volume of 23,192 shares.
Wall Street Analysts Forecast Growth
Separately, JPMorgan Chase & Co. began coverage on shares of Ascentage Pharma Group International in a research note on Thursday. They issued an “overweight” rating on the stock.
Read Our Latest Report on Ascentage Pharma Group International
Ascentage Pharma Group International Price Performance
About Ascentage Pharma Group International
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Featured Articles
- Five stocks we like better than Ascentage Pharma Group International
- How to find penny stocks to invest and trade
- CarMax and Carvana: Steering the Used Car Market
- Retail Stocks Investing, Explained
- How China’s Recovery Could Boost These 3 Platinum Plays
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Fortinet: A Top Cybersecurity Stock With Growth Catalysts
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
